Cells (Jul 2022)

Citalopram Neuroendocrine Challenge Shows Altered Tryptophan and Kynurenine Metabolism in Migraine

  • Kinga Gecse,
  • Andrea Edit Édes,
  • Tamás Nagy,
  • Adrienn Katalin Demeter,
  • Dávid Virág,
  • Márton Király,
  • Borbála Dalmadi Kiss,
  • Krisztina Ludányi,
  • Zsuzsanna Környei,
  • Adam Denes,
  • Gyorgy Bagdy,
  • Gabriella Juhasz

DOI
https://doi.org/10.3390/cells11142258
Journal volume & issue
Vol. 11, no. 14
p. 2258

Abstract

Read online

Altered tryptophan (TRP) metabolism may have an important role in migraine susceptibility through its main metabolites, serotonin and kynurenine (KYN). Both affect pain processing and stress response by interfering with neural and brain hypersensitivity and by interacting with chemokines and cytokines that control vascular and inflammatory processes. The involvement of these pathways in migraine has been widely studied, but acute citalopram neuroendocrine challenge on TRP metabolism and cytokine profile has not been investigated yet. In our study, females with episodic migraine without aura and healthy controls were studied before and after acute citalopram or placebo in a double-blind setting. At baseline, increased TRP/large neutral amino acid (LNAA) ratio and decreased RANTES chemokine concentration were detected in migraine patients compared to controls. The challenge induced a significant increase in TRP, KYN, and TRP/LNAA in healthy controls, but not in migraine patients. Furthermore, migraine attack frequency negatively correlated with KYN/TRP ratio and positively correlated with the neuroendocrine-challenge-induced KYN concentration increase. Our results support a decreased breakdown of TRP via KYN pathway and a failure to modulate TRP–KYN pathway during citalopram-induced acute stress together with an increased vascular sensitivity in migraine. These mechanisms may provide useful drug targets for future drug development.

Keywords